Ationdo SR 200mg tablets
BNF presentation 0407020AGBCAEAF within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020AGBCAEAF
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
407
NHS spend (£)
£23,515.50
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 77 |
| February 2025 | 2 |
| December 2024 | 21 |
| November 2024 | 83 |
| October 2024 | 103 |
| August 2024 | 4 |
| July 2024 | 95 |
| May 2024 | 22 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 13 | No data available |
| Unknown pharmacy | 12 | No data available |
| Unknown pharmacy | 11 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 10 | No data available |
| Unknown pharmacy | 9 | No data available |
| Unknown pharmacy | 9 | No data available |